Ignite Creation Date:
2025-12-26 @ 2:42 PM
Ignite Modification Date:
2026-02-09 @ 7:03 AM
Study NCT ID:
NCT02382406
Status:
TERMINATED
Last Update Posted:
2023-05-23
First Post:
2015-02-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC
Sponsor:
Nisha Mohindra, MD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HCRN LUN13-175
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None